Yield10 Bioscience, Inc.
About Yield10 Bioscience, Inc.
Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 is leveraging an extensive track record of innovation based around optimizing the flow of carbon in living systems. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing seed production, Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn. Yield10 is based in Woburn, MA.YEAR FOUNDED:
1992
LEADERSHIP:
CEO: Oliver P. Peoples
CAO: Charles B. Haaser
CSO: Kristi Snell
FOLLOW YIELD10 BIOSCIENCE:
Tweets by Yield10 Bioscience
53 articles with Yield10 Bioscience, Inc.
-
Yield10 Bioscience to Present at the LD Virtual Invitational XI on June 9, 2021
5/27/2021
Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will give a corporate presentation at the LD Micro Virtual Invitational XI investor conference on Wednesday, June 9, 2021 at 3:30 pm ET, Track Two. The virtual conference and presentation will be held via webcast from June 8 to 10, 2021.
-
Yield10 Bioscience to Participate at the Benzinga Global Small Cap Conference on May 14, 2021
5/10/2021
Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that management will participate at the Benzinga Global Small Cap Conference on May 14, 2021.
-
Yield10 Bioscience to Announce First Quarter 2021 Financial Results and Host a Conference Call on Tuesday, May 11, 2021
5/4/2021
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its first quarter 2021 financial results and provide a corporate update on Tuesday, May 11, 2021.
-
Yield10 Bioscience to Present at the Benzinga Biotech Small Cap Conference on March 25, 2021
3/18/2021
Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that it will be featured as a presenting company at the Benzinga Biotech Small Cap Conference to be held on March 24-25, 2021 in a virtual format.
-
Yield10 Bioscience Announces Fourth Quarter and Full Year 2020 Financial ResultsManagement will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update
3/16/2021
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and twelve months ended December 31, 2020.
-
Yield10 Bioscience to Present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference
3/11/2021
Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announces that Chief Executive Officer Oliver Peoples, PhD. will present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference to be held March 17-19, 2021
-
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2020 Financial Results and Host a Conference Call on Tuesday, March 16, 2021
3/9/2021
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2020 financial results and provide a corporate update on Tuesday, March 16, 2021.
-
Yield10 Bioscience to Present at Bank of America 2021 Virtual Global Agriculture & Materials Conference on March 4, 2021
3/1/2021
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced it will be featured as a presenting company at the Bank of America 2021 Virtual Global Agriculture & Materials Conference being held on March 3-4, 2021. On Thursday, March 4, 2021 at 7:00 am Eastern Time,
-
Yield10 Bioscience Announces Closing of $12.7 Million Public Offering
2/3/2021
Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per share.
-
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering - Feb 01, 2021
2/1/2021
Yield10 Bioscience, Inc., an agricultural bioscience company, announced the pricing of its underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per share.
-
Yield10 Bioscience Announces Proposed Public Offering of Common Stock
1/29/2021
Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has commenced an underwritten public offering of shares of its common stock.
-
Yield10 Bioscience Announces Achievement of Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina Plants
1/19/2021
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced successful field testing of prototype lines of the oilseed Camelina sativa that have been programed to produce PHA bioplastics directly in seed. PHA are natural polymers, prevalent in nature and fully biodegradable in the environment. Currently produced by fermentation of engineered microbes, PHA polymers also have applications in water treatment where
-
Yield10 Bioscience Announces Third Quarter 2020 Financial Results
11/12/2020
Yield10 Bioscience, Inc., an agricultural bioscience company, reported financial results for the three and nine months ended September 30, 2020.
-
Yield10 Bioscience to Announce Third Quarter 2020 Financial Results and Host a Conference Call on Thursday, November 12, 2020
11/5/2020
Yield10 Bioscience, Inc. (NASDAQ: YTEN), an agricultural bioscience company, announced today that the Company will report its third quarter 2020 financial results and provide a corporate update on Thursday, November 12, 2020. Management will host a conference call on Thursday, November 12, 2020 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following management’s formal remarks,
-
Yield10 Bioscience Announces Start of Field Tests of Winter Camelina Varieties
10/28/2020
Yield10 Bioscience, Inc., an agricultural bioscience company, announced that it has begun field testing to evaluate the emergence and agronomics of winter Camelina sativa varieties.
-
Yield10 Bioscience Announces Participation at The H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)
9/9/2020
Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference. The conference is being held on September 14-16, 2020 virtually. Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will provide an overview of the Company's business during the live presentation on Monday, September 14, 2
-
Yield10 Bioscience Announces Closing of $4.0 Million Public Offering, Including Exercise of the Over-Allotment Option, and Concurrent $1.7 Million Private Placement
8/26/2020
Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten public offering of 835,000 shares of its common stock at a public offering price of $4.25 per share. In addition, Maxim Group LLC has exercised its over-allotment option to purchase 116,835 shares of common stock, at the public offering price less underwriting discounts. Gross proceeds before deductin
-
Yield10 Bioscience Announces Pricing of $5.2 Million Public Offering and Concurrent Private Placement
8/23/2020
Yield10 Bioscience, Inc., an agricultural bioscience company, announced the pricing of its underwritten public offering of 835,000 shares of its common stock at a public offering price of $4.25 per share.
-
Yield10 Bioscience Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
8/21/2020
Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has commenced an underwritten public offering of shares of its common stock.
-
Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulated Status of its CRISPR Genome-Edited C3007 Trait in Canola; Plans U.S. Field Tests for 2021
8/17/2020
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has obtained a positive response from USDA-APHIS’s Biotechnology Regulatory Services (BRS) for its CRISPR genome-edited trait C3007 in canola plant lines developed for increased oil content. Yield10’s submission along with the USDA-APHIS BRS response is posted on the USDA’s website . In June 2020, Yield10 submitted an “Am I regulated?” let